Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systems
S Mirzaei, MK Mahabady, A Zabolian, A Abbaspour… - Life Sciences, 2021 - Elsevier
Glioblastoma multiforme (GBM) is one of the worst brain tumors arising from glial cells,
causing many deaths annually. Surgery, chemotherapy, radiotherapy and immunotherapy …
causing many deaths annually. Surgery, chemotherapy, radiotherapy and immunotherapy …
A review of the current status of siRNA nanomedicines in the treatment of cancer
P Resnier, T Montier, V Mathieu, JP Benoit, C Passirani - Biomaterials, 2013 - Elsevier
RNA interference currently offers new opportunities for gene therapy by the specific
extinction of targeted gene (s) in cancer diseases. However, the main challenge for nucleic …
extinction of targeted gene (s) in cancer diseases. However, the main challenge for nucleic …
Advances in porous silicon–based nanomaterials for diagnostic and therapeutic applications
T Tieu, M Alba, R Elnathan… - Advanced …, 2019 - Wiley Online Library
This review provides a perspective on porous silicon (pSi)–based nanomaterials including
nanoparticles, nanowires, and thin films, that are currently being used in advanced therapy …
nanoparticles, nanowires, and thin films, that are currently being used in advanced therapy …
The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting
NT Huynh, E Roger, N Lautram, JP Benoît… - …, 2010 - Taylor & Francis
Research in designing and engineering long-circulating nanoparticles, so-called
'stealth'nanoparticles, has been attracting increasing interest as a new platform for targeted …
'stealth'nanoparticles, has been attracting increasing interest as a new platform for targeted …
Engineering nanocarriers for siRNA delivery
The discovery of RNA interference has revitalized the long ongoing pursuit of gene therapy
for the treatment of diseases. Nevertheless, despite promising results from experimental …
for the treatment of diseases. Nevertheless, despite promising results from experimental …
Delivery of synthetic mRNAs for tissue regeneration
H Steinle, J Weber, S Stoppelkamp… - Advanced drug delivery …, 2021 - Elsevier
In recent years, nucleic acid-based therapeutics have gained increasing importance as
novel treatment options for disease prevention and treatment. Synthetic messenger RNAs …
novel treatment options for disease prevention and treatment. Synthetic messenger RNAs …
Small interfering RNA from the lab discovery to patients' recovery
M Caillaud, M El Madani… - Journal of Controlled …, 2020 - Elsevier
In 1998, the RNA interference discovery by Fire and Mello revolutionized the scientific and
therapeutic world. They showed that small double-stranded RNAs, the siRNAs, were …
therapeutic world. They showed that small double-stranded RNAs, the siRNAs, were …
Delivery systems and local administration routes for therapeutic siRNA
FTMC Vicentini, LN Borgheti-Cardoso, LV Depieri… - Pharmaceutical …, 2013 - Springer
With the increasing number of studies proposing new and optimal delivery strategies for the
efficacious silencing of gene-related diseases by the local administration of siRNAs, the …
efficacious silencing of gene-related diseases by the local administration of siRNAs, the …
Development of RNAi technology for targeted therapy—a track of siRNA based agents to RNAi therapeutics
RNA interference (RNAi) was intensively studied in the past decades due to its potential in
therapy of diseases. The target specificity and universal treatment spectrum endowed siRNA …
therapy of diseases. The target specificity and universal treatment spectrum endowed siRNA …
Innovative lipoplexes formulations with enhanced siRNA efficacy for cancer treatment: where are we now?
Over the past two decades, RNA interference has become an extensively studied
mechanism to silence gene and treat diseases including cancer. siRNA appears as a …
mechanism to silence gene and treat diseases including cancer. siRNA appears as a …